Granite Point Capital Management, L.P. Global Blood Therapeutics, Inc. Transaction History

Granite Point Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$38.0 - $51.1 $1.14 Million - $1.53 Million	-30,000 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$38.7 - $50.15 $375,390 - $486,455	9,700 Added 47.78%	30,000 $1.36 Million
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $186,120 - $309,730	-4,700 Reduced 18.8%	20,300 $980,000
Q4 2017 Feb 08, 2018	BUY	$29.7 - $45.7 $742,500 - $1.14 Million	25,000	25,000 $984,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.